PHS
RAMP icon

PFM Health Sciences’s LiveRamp RAMP Stock Holding History

PFM Health Sciences’s Portfolio RAMP Stock Details RAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-236,405
Closed -$9.13M – 111
2018
Q4 		$9.13M Sell
236,405
-379,362
-62% -$17.2M 0.24% 75
2018
Q3 		$30.4M Buy
+615,767
New +$27.3M 0.45% 78

Other funds holding RAMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

PFM Health Sciences's RAMP Position: Q1 2019 in Review

PFM Health Sciences sold out of LiveRamp (RAMP) in Q1 2019, closing a stake of 236,405 shares — an estimated $9.13M sold.

PFM Health Sciences first reported a position in RAMP in Q3 2018 and held it in 2 quarters. The position peaked at $30.4M in Q3 2018. 245 funds tracked by Wall St. Rank hold RAMP as of Q1 2019.

  • PFM Health Sciences reported no remaining LiveRamp position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 236,405 LiveRamp shares in Q1 2019, an estimated $9.13M.
  • PFM Health Sciences first reported a position in LiveRamp in Q3 2018 and held it in 2 quarters.
  • PFM Health Sciences's LiveRamp position peaked at $30.4M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held LiveRamp as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.